Two Ulcerative Colitis Biologics: Same Clinical Difference?
While infliximab (Remicade) and vedolizumab (Entyvio) were comparable for clinical remission in previously biologic-naive ulcerative colitis patients, infliximab was more likely to result in corticosteroid-free clinical remission as well as endoscopic remission, a post-hoc analysis found. At 1 year, a similar percentage of ulcerative colitis patients reached clinical remission from infliximab and vedolizumab (39.9% vs […]
New dietary treatment for epilepsy well tolerated and reduced seizures, study finds
The first clinical trial of a new dietary treatment for children and adults with severe forms of epilepsy, co-developed by UCL researchers and based on the ketogenic diet, has been successfully completed. For the study, published in Brain Communications, clinicians evaluated the use of K.Vita®, (also known as Betashot), an oral liquid dietary supplement developed […]
Biomaterial vaccines ward off broad range of bacterial infections and septic shock
Current clinical interventions for infectious diseases are facing increasing challenges due to the ever-rising number of drug-resistant microbial infections, epidemic outbreaks of pathogenic bacteria, and the continued possibility of new biothreats that might emerge in the future. Effective vaccines could act as a bulwark to prevent many bacterial infections and some of their most severe […]
Cancer and the Heart; COVID and Dx Delays; Not the Same Old Accelerated Approval?
The European Society of Cardiology has launched a clinical trial to evaluate cardiac MRI during chemotherapy to prevent treatment-related heart failure in patients with cancer. A large retrospective study showed that patients with heart failure had a significantly increased risk of developing cancer. (ESC Heart Failure) The American Heart Association awarded $11 million in grants […]